Screening in public health

dc.contributor.author	Γουρουντή, Κλεάνθη	el
dc.contributor.author	Λυκερίδου - Αβραμιώτη, Κατερίνα	el
dc.date.accessioned	2015-05-18T17:10:36Z
dc.date.issued	2015-05-18
dc.identifier.uri	http://hdl.handle.net/11400/10680
dc.rights	Αναφορά Δημιουργού-Μη Εμπορική Χρήση-Όχι Παράγωγα Έργα 3.0 Ηνωμένες Πολιτείες	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/3.0/us/	*
dc.source	http://pharmakonpress.gr/	el
dc.subject	Prevention
dc.subject	Screening
dc.subject	Down Syndrome Screening
dc.subject	Principles
dc.subject	Validity
dc.subject	Reliability
dc.subject	Medical Consequences
dc.subject	Psychological Consequences
dc.subject	Informed Choice
dc.subject	Πρόληψη
dc.subject	Έλεγχος
dc.subject	Έλεγχος για Σύνδρομο Down
dc.subject	Αρχές
dc.subject	Εγκυρότητα
dc.subject	Εμπιστευσιμότητα
dc.subject	Ιατρικές συνέπειες
dc.subject	Ψυχολογικές συνέπειες
dc.subject	Συνειδητή επιλογή
dc.title	Screening in public health	en
heal.type	journalArticle
heal.secondaryTitle	case of antenatal screening for down’s syndrome	en
heal.classification	Medicine
heal.classification	Midwifery
heal.classification	Ιατρική
heal.classification	Μαιευτική
heal.classificationURI	http://id.loc.gov/authorities/subjects/sh00006614
heal.classificationURI	http://id.loc.gov/authorities/subjects/sh96006072
heal.classificationURI	N/A-Ιατρική
heal.classificationURI	N/A-Μαιευτική
heal.dateAvailable	10000-01-01
heal.language	en
heal.access	forever
heal.recordProvider	Σχολή Επαγγελμάτων Υγείας και Πρόνοιας. Τμήμα Μαιευτικής	el
heal.publicationDate	2005
heal.bibliographicCitation	Gourounti, K. and Lykeridou, K. (2005) Screening in public health: case of antenatal screening for down’s syndrome. "Epitheorese Klinikes Farmakologias kai Farmakokinetikes", 19 (3), 117-125. Available from: http://pharmakonpress.gr/?p=3392 [Accessed: 18/05/2015].	en
heal.abstract	It is widely acceptable the principle which suggests that prevention is better than cure and screening is a major strategy of secondary prevention. According to UK National Screening Committee (1998) screening could be defined as: the systematic application of a test or enquiry, to identify individuals at sufficient risk of a specific disorder to warrant further investigation or direct preventive action, amongst persons who have not sought medical attention on account of symptoms of that disorder. According to guidelines of WHO and of other professional bodies screening programs should be based on principles concerning the viability, effectiveness and appropriateness of a screening program. Although it is considered that the screening tests that are used in present follow the proposed principles it has been proved that the screening tests carry not only benefits but also risks. The major risk of screening test is the proportion of the false positive and the false negative results, because of their medical, psychological, ethical and legal consequences. Screening for Down syndrome, which now is widely practiced, it can be used as an example that reflects the medical, psychological, economical and ethical implications of screening. For example, the medical con-sequences of a false positive result in the case of antenatal screening for Down syndrome may include unnecessary invasive procedures (amniocentecis, chorionic villus sampling), the physical consequences of them and also adverse outcome of the pregnancy. Although screening has a great contribution in reduction of mortality and morbidity it must be also considered that screening have many implications and consequences. Therefore the informed consent of individuals towards screening is necessary.	en
heal.publisher	Πλέσσα, Ελένη Σ.	el
heal.journalName	Epitheorese Klinikes Farmakologias kai Farmakokinetikes	en
heal.journalType	peer-reviewed
heal.fullTextAvailability	false